Molecular Pathology | Tissuepathology.com

ASCO: Now and Then

Dr. Keith J. Kaplan — Thu, 11 Jun 2026 18:00:28 +0000

In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in downtown Chicago was $1000/month. I wasshort over $300 a […]

The post ASCO: Now and Then first appeared on Tissuepathology.com.

At the AMP 2025 Annual Meeting, Hundreds Jam Room to Hear About cfDNA Testing

Erica Goodpaster — Wed, 26 Nov 2025 12:58:12 +0000

Association for Molecular Pathology gathering also served up an advocacy push for RESULTS Act passage. The Association for Molecular Pathology (AMP) 2025 Annual Meeting brought together just over 3,000 attendees, and an estimated 420 of them—an impressive 14% of total attendance—sought out information about cell-free DNA (cfDNA) testing. Walking through the convention center in Boston […]

The post At the AMP 2025 Annual Meeting, Hundreds Jam Room to Hear About cfDNA Testing first appeared on Tissuepathology.com.

PathGroup Chooses Mindpeak to Power Its Digital Pathology Transformation

Erica Goodpaster — Tue, 11 Nov 2025 13:10:59 +0000

PathGroup and Mindpeak: Collaboration accelerates AI adoption across one of the world’s largest fully digital laboratory networks HAMBURG, GERMANY, November 11, 2025 /EINPresswire.com/ — Mindpeak, a global pioneer in AI-powered pathology solutions, today announced a strategic collaboration with PathGroup, a premier provider of anatomic, clinical, molecular and digital pathology services. The collaboration marks a significant […]

The post PathGroup Chooses Mindpeak to Power Its Digital Pathology Transformation first appeared on Tissuepathology.com.

Artificial Intelligence in Pathology – Has It’s Time Come?

Dr. Keith J. Kaplan — Wed, 17 Sep 2025 19:36:31 +0000

Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI’s datasets from 7 million slides, perhaps most of which were from Memorial Sloan Kettering Cancer Center. Critics were quick to point out […]

The post Artificial Intelligence in Pathology – Has It’s Time Come? first appeared on Tissuepathology.com.

Digital pathology is just pathology, but does it matter anymore?

Dr. Keith J. Kaplan — Tue, 16 Jan 2024 21:24:13 +0000

Since the 1990s, many innovators to Fortune 500 and Fortune 50 companies have worked to make digital pathology a reality. While not mainstream and perhaps less than 10% of US based pathology groups have any serious implementations of digital pathology, the technology has caught up to our retinas and the legal, regulatory, and business practices […]

The post Digital pathology is just pathology, but does it matter anymore? first appeared on Tissuepathology.com.

World‘s First Automated High Throughput Tissector Launched by Medtech Innovator Xyall

Erica Goodpaster — Tue, 20 Jul 2021 14:32:29 +0000

Delivering faster, more accurate and efficient tissue dissection Eindhoven, THE NETHERLANDS (July 20, 2021) – Xyall BV, a leading medtech innovator in molecular pathology, launches its Tissector High Throughput (HT) system for greater precision diagnostics. This is a world first – enabling high volume, molecular diagnostic laboratories to capitalize commercially on the company’s unique, automated, […]

The post World‘s First Automated High Throughput Tissector Launched by Medtech Innovator Xyall first appeared on Tissuepathology.com.